Search

everythinglearnresearchcommunity

for

Search:↓

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Early diagnosis and treatment of hereditary vitamin D-resistant rickets (HVDRR) are crucial to prevent growth issues and other health problems.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Sodium valproate is effective in treating epilepsy, especially in patients who don't respond to other medications.

The drug combination significantly reduced epileptic drop attacks in patients.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Valproate is effective for epilepsy but has side effects and requires careful monitoring.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

Long-term use of seizure medications can disrupt calcium metabolism, but this can be treated with vitamin D or UV light and does not affect seizure control.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Long-term sodium valproate treatment for epilepsy generally caused mild and temporary side effects.

Neurosteroids help reduce seizures, but their withdrawal increases seizure activity.

Midazolam's antiseizure effects are mainly due to synaptic GABA-A receptors, not neurosteroids or extrasynaptic receptors.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.

Sodium valproate improved epilepsy control in most children but often caused weight gain and other mild side effects.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Progesterone can reduce seizures without relying on the GABAA receptor pathway.

Combining sodium valproate with other epilepsy drugs increases ammonia levels and side effects.

Sodium valproate improved epilepsy control but often caused weight gain in children.

Low dose valproate in epileptic children mainly causes weight gain and other non-life-threatening side effects.

The patches could quickly deliver epilepsy treatment and reduce seizures.

Neurosteroid production in the brain may delay seizure onset.

Effective epilepsy management involves accurate diagnosis, understanding seizure types, identifying causes, and choosing the right treatment.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.